pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·4h ago·1 min read
save

Bayer outlines $2.2 billion Ohio plant that will add roughly 600 jobs

Oct 2, 2026·read at Endpoints ↗Positive

Bayer announced its plan for a new manufacturing complex in New Albany, Ohio, with an investment of about $2.2 billion.

The facility is expected to create roughly 600 new jobs in the region, supporting local employment and the company's production capacity.

The company described the site as part of its broader strategy to expand manufacturing capabilities in the United States.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Bayer unpacks plans for $2.2B manufacturing site in Ohio”

read at Endpoints ↗
90 words · retrieved 3h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Sionna Therapeutics, Inc.
topics
Ophthalmology

related stories

  • Sep 21Novo aims to diversify with new pipeline assets and bolt-on dealsEndpoints
  • May 5Cytokinetics heart drug scores in closely watched trialBioPharma Dive
  • May 5What you need to know about hantavirus (don’t panic)STAT
  • May 4Supreme Court restores mifepristone access by mailEndpoints
  • May 4With $97M, Latus pursues a different kind of Huntington’s gene therapyBioPharma Dive